Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
North Carolina Voter Guide 2024: Who's running, how, where, when to vote in NC election
Recommended
Help North Carolina rebuild: WRAL's Hurricane Helene recovery fund raises $900K+
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Rapport Therapeutics, Inc.
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
September 05, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
August 29, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
August 08, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
July 29, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
June 12, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Rapport Therapeutics Announces Pricing of Initial Public Offering
June 06, 2024
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Rapport Therapeutics Appoints Pioneering Industry Leader John Maraganore to Board of Directors
March 19, 2024
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Appoints Chief People Officer
February 28, 2024
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors
January 16, 2024
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Appoints Chief Financial Officer
October 30, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Appoints Chief Operating Officer and Scientific Advisory Board Member
September 07, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform
August 23, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Names Scientific Advisory Board
June 29, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Rapport Therapeutics Launches with $100 Million to Transform the Treatment of Neurological Disease through the Discovery and Development of Precision Therapies
March 07, 2023
From
Rapport Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.